4DMedical Limited (ASX:4DXO)

Market Cap	1.19B +542.4%
Revenue (ttm)	5.85M +55.9%
Net Income	-30.07M
EPS	-0.14
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150,526
Average Volume	395,358
Open	2.250
Previous Close	2.220
Day's Range	2.160 - 2.370
52-Week Range	0.002 - 2.370
Beta	n/a
RSI	83.21
Earnings Date	Nov 27, 2025

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of poten...

• Industry: Prepackaged Software
• Founded: 2012
• Employees: 124
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: 4DXO